133 Houndsditch | Liverpool St | London
4-5 February, 2020
Showcase opportunities exist in the 2020 congress for companies looking to raise finance (Inv€$table) and / or attract a licensing deal (Lic€n$able)
These showcases are for all stages of private and public companies to present news and deal flow or pitch an audience of active investors, pharma, medtech commercial leaders and big tech.
Inv€$table and Lic€n$able showcases are 12-minute showcases allowing companies to deliver succinct, hard hitting and insightful presentations to an audience seeking to uncover innovative research and/or technology for both capital and strategic transactions and R&D collaborations.
Presenting company executives will present to a live audience, plus have their showcases video recorded and turned into a post-event IR piece.
If you need a platform to announce news/deal flow, are actively looking to raise capital or attract licensing deals with life science and tech investors, pharma, medtech commercial leaders and big tech, then a showcase is your best opportunity to get noticed at the LSX World Congress.
- Biotech showcase opportunities exist for, but not exclusively: Drug Discovery, Pre-Clinical, Clinical and OTM Therapeutics companies.
- Medtech showcase opportunities exist for MedSurg, IV Diagnostics, Devices, Medical Imaging and Orthopaedic companies
- Healthtech showcase opportunities exist for, but not exclusively: Digital Health, AI, Big Data, Blockchain, Predictive Analytics and Machine Learning companies.
PLUS, NEW FOR 2020, Pharma BD&L Executives are able to position their company as a 'Therapeutic Partner of Choice' and headline 1 of 5 therapeutic sector sessions with their licensing, partnering preferences and external innovation strategies. Each presentation will headline a specific therapeutic licensing session followed by 7 showcases.
In total, over 100 showcases will be delivered at the congress. To secure one, enquire below.